"Ropren delivers everything that Lipitor does re lowering Colesterol but without the liver and memory side effects"
Swinburne said it normalised colesterol levels, which is even better, as well as fixing the liver, rather than damaging it.
I can see why people think sla's market cap is high, but if Ropren can do what the company (& Swinburne) says it can the company should be worth billions.
Add to My Watchlist
What is My Watchlist?
